Product Details

Jyna Dolutegravir, Lamivudine and Tenofovir Disoproxil

Dolutegravir (Dolutegravir Sodium); Lamivudine; Tenofovir Disoproxil Fumarate
50 mg; 300 mg; 300 mg
Tablet

ROA

Oral

Applicant Name

Jyna Pharma Ltd

NRN

C4-0363

Status

Active


Composition

 

ATC Code

J05AR27  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

 

Product Description

424 Jyna Dolutegravir, Lamivudine And Tenofovir Disopr C4-0363 Dolutegravir, Lamivudine And Tenofovir Disoproxil Dolutegravir Sodium = Sodium (Ras)--{[(-Difluorophenyl)Methyl]Carbamoyl}-- Methyl-,-Dioxo-,,A-Hexahydro- H-Pyrido[’’:]Pyrazino[-B][,]Oxazin--Olate. = Chfnnao Lamivudine = (H)-Pyrimidinone,-Amino--[-(Hydroxyl Methyl)-,-Oxathiolan -Yl]-, (R-Cis)-; Or (-)--[(R,S)--(Hydroxylmethyl)-,-Oxathiolan-Yl]-Cytosine Or (-)--Amino--[(R,S)--(Hydroxymethyl)-,-Oxathiolan-Yl]-Pyrimidin-(H)-One = Chnos Tenofovir Disoproxil Fumarate = -[(R Anti-Infectives Oral (4r,12as)-9-{2,4--4- 6,8-3,4,6,8,12,12a-- 2h-[1’,2’:4,5][2,1-B][1,3]-. = 2(1h)-1-[2--1,3- -5-Yl]-, (2r-Cis)-; Or (-)-1-[(2r,5s)-2-)-1,3--5-Yl]-R (-)-4-Amino-1-[(2r,5s)-2-)-1,3--5--2(1h)- = 9-[(R Tablet, Film Coated Prescription Only Medicine (Pom) Jyna Pharma Ltd Laurus Labs India 2021-05-07 2026-05-06

Manufacturer Name

Laurus Labs Limited

Manufacturer Country

INDIA  

Approval Date

2021-05-07  

Expiry Date

2026-05-06